{"": [121, 1270, 0], "Introduction": [1271, 5500, 0], "Design and modeling framework": [5524, 6318, 0], "Bayesian inference of seroprevalence": [6319, 9179, 0], "Propagating serological uncertainty through models": [9180, 10150, 0], "Single-population SEIR model with social distancing and serology": [10151, 11043, 0], "Age-structured SEIR model with serology": [11044, 12360, 0], "Serosurvey sample size and allocation for inference and modeling": [12361, 14511, 0], "Data sources": [14512, 15781, 0], "Materials and methods": [5501, 15781, 1], "Test sensitivity/specificity, sampling bias, and true seroprevalence influence the accuracy and robustness of estimates": [15791, 18967, 0], "Seroprevalence estimates inform uncertainty in epidemic peak, timing, and reproductive number": [18968, 22573, 0], "Strategic sample allocation improves estimates": [22574, 23678, 0], "Results": [15782, 23678, 1], "Discussion": [23679, 32502, 0]}